Synopsis of recent research by authors named "Alejandro Perez Fidalgo"
- Alejandro Perez Fidalgo's recent research primarily focuses on advanced ovarian cancer, exploring various treatment strategies, including maintenance therapies with PARP inhibitors, and the impact of immunotherapy combined with chemotherapy in recurrent cases, as seen in his multicenter trials and Delphi studies.
- His work also extends to evaluating the cost-effectiveness of combining olaparib with bevacizumab for patients with homologous recombination deficiency-positive advanced ovarian cancer, highlighting the importance of economic factors in treatment decision-making.
- Additionally, Perez Fidalgo investigates the incidence and survival outcomes of gastrointestinal stromal tumors (GISTs) and assesses novel treatments for endometrial cancer, showcasing a commitment to understanding and improving cancer management across different types.